{"entity":{"type":"insider","cik":"0001611156","url":"/insider/0001611156","json_url":"/insider/0001611156.json","name":"Luo Mary Z.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":78,"n_filings":22,"first":"2015-06-09","last":"2024-01-11","span_basis":"filed_date"},"name_variants":[{"name":"Luo Mary Z.","source":"filing","n_filings":22,"first_seen":"2015-06-09","last_seen":"2024-01-11"}],"transactions":[{"id":3153756,"accession":"0001104659-24-003330","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-003330","line_url":"/filing/0001104659-24-003330","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (COO,Chief Scientist & Chairman), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"COO,Chief Scientist & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131386.0,"shares_display":"131,386","price_per_share":54.585478996240084,"price_display":"54.59","price_state":"stated","total_value":7171767.7434,"total_display":"7,171,767.74","total_whole":"7,171,768","shares_owned_after":1157566.0,"shares_owned_after_display":"1,157,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-11","scope":"insider","n_lines":4},{"id":3231819,"accession":"0001104659-24-003050","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001104659-24-003050","line_url":"/filing/0001104659-24-003050","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (COO,Chief Scientist & Chairman), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"COO,Chief Scientist & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86156.0,"shares_display":"86,156","price_per_share":57.14322488044942,"price_display":"57.14","price_state":"stated","total_value":4923231.6828,"total_display":"4,923,231.68","total_whole":"4,923,232","shares_owned_after":1271280.0,"shares_owned_after_display":"1,271,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-10","scope":"insider","n_lines":3},{"id":3231808,"accession":"0001104659-24-003050","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-24-003050","line_url":"/filing/0001104659-24-003050","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (COO,Chief Scientist & Chairman), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"COO,Chief Scientist & Chairman","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133644.0,"shares_display":"133,644","price_per_share":58.928769165095325,"price_display":"58.93","price_state":"stated","total_value":7875476.4263,"total_display":"7,875,476.43","total_whole":"7,875,476","shares_owned_after":1395462.0,"shares_owned_after_display":"1,395,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-10","scope":"insider","n_lines":7},{"id":6418510,"accession":"0001104659-22-063844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-063844","line_url":"/filing/0001104659-22-063844#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10650.0,"shares_display":"10,650","price_per_share":34.2127,"price_display":"34.21","price_state":"stated","total_value":364365.255,"total_display":"364,365.26","total_whole":"364,365","shares_owned_after":2104143.0,"shares_owned_after_display":"2,104,143","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":6171457,"accession":"0001104659-22-063416","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-22-063416","line_url":"/filing/0001104659-22-063416","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41730.0,"shares_display":"41,730","price_per_share":33.75893991133477,"price_display":"33.76","price_state":"stated","total_value":1408760.5625,"total_display":"1,408,760.56","total_whole":"1,408,761","shares_owned_after":2114908.0,"shares_owned_after_display":"2,114,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-20","scope":"insider","n_lines":2},{"id":6171447,"accession":"0001104659-22-063416","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-063416","line_url":"/filing/0001104659-22-063416","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67046.0,"shares_display":"67,046","price_per_share":34.14224154759419,"price_display":"34.14","price_state":"stated","total_value":2289100.7268,"total_display":"2,289,100.73","total_whole":"2,289,101","shares_owned_after":2168305.0,"shares_owned_after_display":"2,168,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-20","scope":"insider","n_lines":3},{"id":6537073,"accession":"0001104659-22-062438","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-062438","line_url":"/filing/0001104659-22-062438","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50376.0,"shares_display":"50,376","price_per_share":35.75988002421788,"price_display":"35.76","price_state":"stated","total_value":1801439.7161,"total_display":"1,801,439.72","total_whole":"1,801,440","shares_owned_after":2226406.0,"shares_owned_after_display":"2,226,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-18","scope":"insider","n_lines":2},{"id":6537067,"accession":"0001104659-22-062438","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-062438","line_url":"/filing/0001104659-22-062438","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68069.0,"shares_display":"68,069","price_per_share":35.74986227651354,"price_display":"35.75","price_state":"stated","total_value":2433457.3753,"total_display":"2,433,457.38","total_whole":"2,433,457","shares_owned_after":2287740.0,"shares_owned_after_display":"2,287,740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider","n_lines":2},{"id":4100689,"accession":"0001104659-21-025361","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-025361","line_url":"/filing/0001104659-21-025361#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":407.0,"shares_display":"407","price_per_share":18.5807,"price_display":"18.58","price_state":"stated","total_value":7562.3449,"total_display":"7,562.34","total_whole":"7,562","shares_owned_after":6827679.0,"shares_owned_after_display":"6,827,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-18","scope":"insider"},{"id":4100686,"accession":"0001104659-21-025361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-025361","line_url":"/filing/0001104659-21-025361#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13801.0,"shares_display":"13,801","price_per_share":18.6742,"price_display":"18.67","price_state":"stated","total_value":257722.6342,"total_display":"257,722.63","total_whole":"257,723","shares_owned_after":6828086.0,"shares_owned_after_display":"6,828,086","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider"},{"id":4100684,"accession":"0001104659-21-025361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-025361","line_url":"/filing/0001104659-21-025361#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16259.0,"shares_display":"16,259","price_per_share":18.5147,"price_display":"18.51","price_state":"stated","total_value":301030.5073,"total_display":"301,030.51","total_whole":"301,031","shares_owned_after":6841887.0,"shares_owned_after_display":"6,841,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":4100647,"accession":"0001104659-21-022246","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-022246","line_url":"/filing/0001104659-21-022246#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Applied Physics & Chemistry Laboratories, Inc.; Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Applied Physics & Chemistry Laboratories, Inc.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13277.0,"shares_display":"13,277","price_per_share":18.9442,"price_display":"18.94","price_state":"stated","total_value":251522.1434,"total_display":"251,522.14","total_whole":"251,522","shares_owned_after":6858146.0,"shares_owned_after_display":"6,858,146","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-12","filed_date":"2021-02-12","scope":"insider"},{"id":4100644,"accession":"0001104659-21-022246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-022246","line_url":"/filing/0001104659-21-022246#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Applied Physics & Chemistry Laboratories, Inc.; Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Applied Physics & Chemistry Laboratories, Inc.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19823.0,"shares_display":"19,823","price_per_share":19.0629,"price_display":"19.06","price_state":"stated","total_value":377883.8667,"total_display":"377,883.87","total_whole":"377,884","shares_owned_after":6871423.0,"shares_owned_after_display":"6,871,423","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-12","scope":"insider"},{"id":4100641,"accession":"0001104659-21-022246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-022246","line_url":"/filing/0001104659-21-022246#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Applied Physics & Chemistry Laboratories, Inc.; Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Applied Physics & Chemistry Laboratories, Inc.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15747.0,"shares_display":"15,747","price_per_share":18.7556,"price_display":"18.76","price_state":"stated","total_value":295344.4332,"total_display":"295,344.43","total_whole":"295,344","shares_owned_after":6891246.0,"shares_owned_after_display":"6,891,246","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":5343900,"accession":"0001104659-21-016790","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-016790","line_url":"/filing/0001104659-21-016790#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Applied Physics & Chemistry Laboratories, Inc.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11927.0,"shares_display":"11,927","price_per_share":18.9298,"price_display":"18.93","price_state":"stated","total_value":225775.7246,"total_display":"225,775.72","total_whole":"225,776","shares_owned_after":6906993.0,"shares_owned_after_display":"6,906,993","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":5343898,"accession":"0001104659-21-016790","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-016790","line_url":"/filing/0001104659-21-016790#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Applied Physics & Chemistry Laboratories, Inc.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13452.0,"shares_display":"13,452","price_per_share":18.8856,"price_display":"18.89","price_state":"stated","total_value":254049.0912,"total_display":"254,049.09","total_whole":"254,049","shares_owned_after":6918920.0,"shares_owned_after_display":"6,918,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":5343896,"accession":"0001104659-21-016790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-016790","line_url":"/filing/0001104659-21-016790#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Applied Physics & Chemistry Laboratories, Inc.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15507.0,"shares_display":"15,507","price_per_share":18.9412,"price_display":"18.94","price_state":"stated","total_value":293721.1884,"total_display":"293,721.19","total_whole":"293,721","shares_owned_after":6932372.0,"shares_owned_after_display":"6,932,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":5369973,"accession":"0001104659-21-013185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-013185","line_url":"/filing/0001104659-21-013185#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.; Applied Physics & Chemistry Laboratories, Inc.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25570.0,"shares_display":"25,570","price_per_share":18.8901,"price_display":"18.89","price_state":"stated","total_value":483019.857,"total_display":"483,019.86","total_whole":"483,020","shares_owned_after":6947879.0,"shares_owned_after_display":"6,947,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":5369970,"accession":"0001104659-21-013185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-013185","line_url":"/filing/0001104659-21-013185#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.; Applied Physics & Chemistry Laboratories, Inc.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16299.0,"shares_display":"16,299","price_per_share":18.3645,"price_display":"18.36","price_state":"stated","total_value":299322.9855,"total_display":"299,322.99","total_whole":"299,323","shares_owned_after":6973449.0,"shares_owned_after_display":"6,973,449","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-05","scope":"insider"},{"id":5403649,"accession":"0001104659-21-011540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-011540","line_url":"/filing/0001104659-21-011540#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13817.0,"shares_display":"13,817","price_per_share":18.6597,"price_display":"18.66","price_state":"stated","total_value":257821.0749,"total_display":"257,821.07","total_whole":"257,821","shares_owned_after":6989748.0,"shares_owned_after_display":"6,989,748","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider"},{"id":5403647,"accession":"0001104659-21-011540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-011540","line_url":"/filing/0001104659-21-011540#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Applied Physics & Chemistry Laboratories, Inc.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24114.0,"shares_display":"24,114","price_per_share":18.2931,"price_display":"18.29","price_state":"stated","total_value":441119.8134,"total_display":"441,119.81","total_whole":"441,120","shares_owned_after":7003565.0,"shares_owned_after_display":"7,003,565","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":8201158,"accession":"0001104659-19-050009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-050009","line_url":"/filing/0001104659-19-050009#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.; Applied Physics & Chemistry Laboratories, Inc.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":20.82,"price_display":"20.82","price_state":"stated","total_value":6246000.0,"total_display":"6,246,000.00","total_whole":"6,246,000","shares_owned_after":7027679.0,"shares_owned_after_display":"7,027,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-12","scope":"insider"},{"id":6481174,"accession":"0001104659-18-073392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-073392","line_url":"/filing/0001104659-18-073392#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43577.0,"shares_display":"43,577","price_per_share":20.4766,"price_display":"20.48","price_state":"stated","total_value":892308.7982,"total_display":"892,308.80","total_whole":"892,309","shares_owned_after":2072317.0,"shares_owned_after_display":"2,072,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-17","scope":"insider"},{"id":6333287,"accession":"0001104659-18-072896","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-072896","line_url":"/filing/0001104659-18-072896#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29689.0,"shares_display":"29,689","price_per_share":20.9898,"price_display":"20.99","price_state":"stated","total_value":623166.1722,"total_display":"623,166.17","total_whole":"623,166","shares_owned_after":7327679.0,"shares_owned_after_display":"7,327,679","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-13","filed_date":"2018-12-13","scope":"insider"},{"id":6333283,"accession":"0001104659-18-072896","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-072896","line_url":"/filing/0001104659-18-072896#line-3","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37469.0,"shares_display":"37,469","price_per_share":21.2105,"price_display":"21.21","price_state":"stated","total_value":794736.2245,"total_display":"794,736.22","total_whole":"794,736","shares_owned_after":7357368.0,"shares_owned_after_display":"7,357,368","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-13","scope":"insider"},{"id":6333279,"accession":"0001104659-18-072896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-072896","line_url":"/filing/0001104659-18-072896","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Luo Mary Z.; Zhang Jack Y.","owner_display_name":"Luo Mary Z.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66757.0,"shares_display":"66,757","price_per_share":21.468159220755876,"price_display":"21.47","price_state":"stated","total_value":1433149.9051,"total_display":"1,433,149.91","total_whole":"1,433,150","shares_owned_after":7398090.0,"shares_owned_after_display":"7,398,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-13","scope":"insider","n_lines":2},{"id":6648997,"accession":"0001104659-18-034167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-034167","line_url":"/filing/0001104659-18-034167#line-2","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":16.0569,"price_display":"16.06","price_state":"stated","total_value":240853.5,"total_display":"240,853.50","total_whole":"240,854","shares_owned_after":2080619.0,"shares_owned_after_display":"2,080,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-17","scope":"insider"},{"id":6648995,"accession":"0001104659-18-034167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-034167","line_url":"/filing/0001104659-18-034167#line-1","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Scientific Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":16.0788,"price_display":"16.08","price_state":"stated","total_value":401970.0,"total_display":"401,970.00","total_whole":"401,970","shares_owned_after":2065619.0,"shares_owned_after_display":"2,065,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-17","scope":"insider"},{"id":3036919,"accession":"0001104659-16-146141","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001104659-16-146141","line_url":"/filing/0001104659-16-146141","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Science Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55081.0,"shares_display":"55,081","price_per_share":20.702862620504348,"price_display":"20.70","price_state":"stated","total_value":1140334.376,"total_display":"1,140,334.38","total_whole":"1,140,334","shares_owned_after":1088835.0,"shares_owned_after_display":"1,088,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-21","filed_date":"2016-09-22","scope":"insider","n_lines":2},{"id":3036909,"accession":"0001104659-16-146141","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-16-146141","line_url":"/filing/0001104659-16-146141#line-6","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Science Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131198.0,"shares_display":"131,198","price_per_share":21.3291,"price_display":"21.33","price_state":"stated","total_value":2798335.2618,"total_display":"2,798,335.26","total_whole":"2,798,335","shares_owned_after":1088335.0,"shares_owned_after_display":"1,088,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-22","scope":"insider"},{"id":3036905,"accession":"0001104659-16-146141","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-16-146141","line_url":"/filing/0001104659-16-146141#line-5","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Science Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95213.0,"shares_display":"95,213","price_per_share":21.3279,"price_display":"21.33","price_state":"stated","total_value":2030693.3427,"total_display":"2,030,693.34","total_whole":"2,030,693","shares_owned_after":752321.0,"shares_owned_after_display":"752,321","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-22","scope":"insider"},{"id":3036901,"accession":"0001104659-16-146141","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-146141","line_url":"/filing/0001104659-16-146141#line-4","is_derivative":false,"issuer_cik":"0001297184","issuer_name":"Amphastar Pharmaceuticals, Inc.","issuer_ticker":"AMPH","issuer_name_source":null,"issuer_url":"/issuer/0001297184","owner_cik":null,"owner_name":"Zhang Jack Y.; Luo Mary Z.","owner_display_name":"Zhang Jack Y.","owner_url":null,"role":"Director, Officer (CEO & Chief Science Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":"CEO & Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":86555.0,"shares_display":"86,555","price_per_share":20.7387,"price_display":"20.74","price_state":"stated","total_value":1795038.1785,"total_display":"1,795,038.18","total_whole":"1,795,038","shares_owned_after":847534.0,"shares_owned_after_display":"847,534","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-20","filed_date":"2016-09-22","scope":"insider"}],"collapsed":true,"next_cursor":"2016-09-20|3036901","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001297184","name":"Amphastar Pharmaceuticals, Inc.","url":"/issuer/0001297184","role":"Director, Officer (COO,Chief Scientist & Chairman), Ten percent owner","n_filings":22,"first_seen":"2015-06-09","last_seen":"2024-01-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001611156","retrieved_at":"2026-08-25T12:10:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}